Medicare Enrolled

Dr. Alyson Simpson, MD

Pediatrics · Gladwyne, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1228 CLUB HOUSE RD, Gladwyne, PA 19035
2674160212
In practice since 2007 (19 years)
NPI: 1538288162 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Simpson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Simpson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Simpson

Dr. Alyson Simpson is a pediatrics specialist in Gladwyne, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Simpson performed 21,362 Medicare services across 409 unique beneficiaries.

Between the years covered by Open Payments, Dr. Simpson received a total of $7,567 from 38 pharmaceutical and/or device companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Simpson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in PA $7,567 industry payments

Medicare Practice Summary

Medicare Utilization ↗
21,362
Medicare services
Top 1% in PA for pediatrics
409
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,124 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 14,779 $30 $70
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
2,850 $3 $12
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
2,213 $13 $30
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
626 $9 $25
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
602 $60 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
153 $103 $175
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
100 $133 $274
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $73 $125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,567
Total received (2018-2024)
Avg $1,081/year across 7 years
Top 6% in PA for pediatrics
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
359
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,512 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,670
2023
$1,825
2022
$1,537
2021
$1,035
2020
$174
2019
$849
2018
$476

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$455
CSL Behring
$197
PFIZER INC.
$166
GENZYME CORPORATION
$163
GlaxoSmithKline, LLC.
$98
Genentech USA, Inc.
$81
Takeda Pharmaceuticals U.S.A., Inc.
$69
Grifols USA, LLC
$66
Amgen Inc.
$65
ABBVIE INC.
$57
Novartis Pharmaceuticals Corporation
$57
kaleo, Inc.
$46
Optinose US, Inc.
$40
BioCryst US Sales Co., LLC
$34
Lilly USA, LLC
$31
LEO Pharma Inc.
$22
Hikma Pharmaceuticals USA
$22
Top 3 companies account for 49.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,566
GlaxoSmithKline, LLC.
$752
GENZYME CORPORATION
$665
CSL Behring
$573
Genentech USA, Inc.
$468
Takeda Pharmaceuticals U.S.A., Inc.
$448
Amgen Inc.
$353
kaleo, Inc.
$312
PFIZER INC.
$297
Regeneron Healthcare Solutions, Inc.
$277
Grifols USA, LLC
$206
Pharming Healthcare, Inc.
$200
Novartis Pharmaceuticals Corporation
$150
Kaleo, Inc.
$143
Boehringer Ingelheim Pharmaceuticals, Inc.
$134
Optinose US, Inc.
$125
Circassia Pharmaceuticals Inc
$114
ALK-Abello, Inc
$99
OptiNose US, Inc.
$68
AIMMUNE THERAPEUTICS, INC.
$62
ABBVIE INC.
$57
SANOFI-AVENTIS U.S. LLC
$55
BioCryst US Sales Co., LLC
$52
Eyevance Pharmaceuticals LLC
$46
LEO Pharma Inc.
$43
Hikma Pharmaceuticals USA
$39
Aimmune Therapeutics, Inc.
$33
AbbVie Inc.
$32
Lilly USA, LLC
$31
Merck Sharp & Dohme LLC
$24
USWM, LLC
$24
Teva Pharmaceuticals USA, Inc.
$23
Octapharma USA, Inc.
$22
Blueprint Medicines Corporation
$17
Incyte Corporation
$16
Aytu BioPharma, Inc.
$15
Bio Products Laboratory USA, Inc.
$15
Philips Electronics North America Corporation
$11
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTIMMUNE · ADBRY · AIRSUPRA · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREZTRI · CIBINQO · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · EUCRISA · FARXIGA · FASENRA · Gammaplex · Haegarda · Hizentra · Karbinal · NIOX VERO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · PALFORZIA · RINVOQ · RUCONEST · Ryaltris · SPIRIVA · SPIRIVA RESPIMAT · SYMBICORT · SYMJEPI · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Tobradex ST · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for pediatrics in PA.

Looking for a pediatrics specialist in Gladwyne?
Compare pediatricians in the Gladwyne area by procedure volume, costs, and industry payment transparency.
Browse pediatricians nearby

Geographic Context

Pediatricians within 10 mi
2,662
Per 100K population
309.1
County median income
$111,521
Nearest hospital
ROXBOROUGH MEMORIAL HOSPITAL
2.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Simpson is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with low-engagement industry engagement in the top 6% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Simpson experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Simpson performed 14,779 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Simpson receive payments from pharmaceutical companies?
Yes. Dr. Simpson received a total of $7,567 from 38 companies across 359 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Simpson's costs compare to other pediatricians in Gladwyne?
Dr. Simpson's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Simpson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →